COVID-19 News, MEDICARE PART B—OIG REPORTS: Annual list of top lab tests reveals COVID-19 drove Part B spending in 2020, (Jan 7, 2022)

By Kristofer Ray, PhD

Increase of $1.5 billion on Covid testing, while non-Covid screenings declined by $1.2 billion, raises questions about the potential long-term impact on beneficiary health.

In its annual list of the top twenty-five lab tests based on Medicare spending OIG reveals that Medicare Part B spending rose from $7.7 billion in 2019 to $8.0 bi ...